Sharing the Burden: The Case for Definitive Local Therapy in Place of Immune Checkpoint Blockade for Patients With a Low-Volume Burden of Metastatic Disease.

Autor:	Lynch C; University of Chicago Medical Center, Department of Radiation and Cellular Oncology, Chicago, IL., Arshad M; University of Chicago Medical Center, Department of Radiation and Cellular Oncology, Chicago, IL., Katipally RR; University of Chicago Medical Center, Department of Radiation and Cellular Oncology, Chicago, IL., Pitroda SP; University of Chicago Medical Center, Department of Radiation and Cellular Oncology, Chicago, IL., Weichselbaum RR; University of Chicago Medical Center, Department of Radiation and Cellular Oncology, Chicago, IL.
Jazyk:	angličtina
Zdroj:	Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 10; Vol. 42 (29), pp. 3387-3391. Date of Electronic Publication: 2024 Jul 22.
DOI:	10.1200/JCO.24.00549
Abstrakt:	Commentary: Sharing the burden of low-volume metastatic cancer between ICB and local treatments.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu